Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
The Latest Breaking News on After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
FDA
4,056 stories
Eli Lilly
510 stories
Food and Drug Administration
310 stories
CMS
263 stories
Biogen
255 stories
Lilly
234 stories
Medicare
170 stories
Lancet
125 stories
Eisai
89 stories
Biogen Inc
79 stories
US Food and Drug Administration
62 stories
National Institutes of Health
60 stories
Queen Mary University of London
53 stories
New England Journal of Medicine
30 stories
Leqembi
24 stories
Alzheimer Association
19 stories
Aduhelm
15 stories
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Topics